Research map: ANCA-associated vasculitis: From immunopathogenesis to diagnosis and toward precision therapy

Back to the article

Papers in this map

  1. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides · J. Charles Jennette · 2012 · 6684 citations · Cited by this paper
  2. Rewiring immunometabolism in hepato-biliary-pancreatic cancers: Unraveling TME-mediated metabolic suppression and advancing next-generation immunotherapeutic approaches · 2026 · Related
  3. Novel cell death program leads to neutrophil extracellular traps · Tobias A. Fuchs · 2007 · 3225 citations · Cited by this paper
  4. Predicting the course: Real-world trajectories toward minimal disease activity in psoriatic arthritis · 2026 · Related
  5. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis · John H. Stone · 2010 · 2776 citations · Cited by this paper
  6. The future of TCR-Treg therapies is renewables · 2026 · Related
  7. Netting neutrophils in autoimmune small-vessel vasculitis · Kai Kessenbrock · 2009 · 1679 citations · Cited by this paper
  8. Pathological reprogramming of innate immune cells drives resistance to biologics in inflammatory bowel diseases · 2026 · Related
  9. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis · Abdul Hakkim · 2010 · 1494 citations · Cited by this paper
  10. Inflammatory biomarkers of atherosclerosis in SLE that may improve SLE-specific cardiovascular risk assessment tools · 2026 · Related
  11. Neutrophil Extracellular Traps Directly Induce Epithelial and Endothelial Cell Death: A Predominant Role of Histones · Mona Saffarzadeh · 2012 · 1352 citations · Cited by this paper
  12. Iron, autoimmunity, and thrombosis: Exploring sex-specific interactions · 2026 · Related
  13. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. · Ronald J. Falk · 1990 · 1267 citations · Cited by this paper
  14. The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation · 2026 · Related
  15. Modification and validation of the Birmingham Vasculitis Activity Score (version 3) · Chetan B. Mukhtyar · 2008 · 1253 citations · Cited by this paper
  16. Fatty acid oxidation and inflammatory bowel disease: Highlighting the roles of pathogenesis and treatment · 2026 · Related
  17. Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis · David R.W. Jayne · 2007 · 1127 citations · Cited by this paper
  18. Aberrant neutrophil and complement activation in thrombotic microangiopathies in pregnancy - Is there a missing link? · 2026 · Related
  19. Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis · Loı̈c Guillevin · 2014 · 1101 citations · Cited by this paper
  20. Anti-neutrophil cytoplasmic antibody-associated vasculitis: biological insights and biomarker-guided disease management · 2026 · Related
  21. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis · Michael E. Wechsler · 2017 · 1094 citations · Cited by this paper
  22. Genetically Distinct Subsets within ANCA-Associated Vasculitis · Paul Lyons · 2012 · 1024 citations · Cited by this paper
  23. RETRACTED: Avacopan for the Treatment of ANCA-Associated Vasculitis · David R.W. Jayne · 2021 · 1018 citations · Cited by this paper
  24. The Five-Factor Score Revisited · Loı̈c Guillevin · 2010 · 956 citations · Cited by this paper
  25. Long-term patient survival in ANCA-associated vasculitis · Oliver Floßmann · 2010 · 946 citations · Cited by this paper
  26. ANCA-associated vasculitis · Arthur Richard Kitching · 2020 · 937 citations · Cited by this paper
  27. Histopathologic Classification of ANCA-Associated Glomerulonephritis · Annelies E. Berden · 2010 · 918 citations · Cited by this paper
  28. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis · Michael W. Walsh · 2020 · 899 citations · Cited by this paper
  29. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis · Kirsten de Groot · 2005 · 800 citations · Cited by this paper
  30. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update · Bernhard Hellmich · 2023 · 753 citations · Cited by this paper
  31. Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis · Coen A. Stegeman · 1994 · 729 citations · Cited by this paper
  32. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis · Sharon A. Chung · 2021 · 697 citations · Cited by this paper
  33. Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic Autoantibodies · Hong Xiao · 2007 · 571 citations · Cited by this paper
  34. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg‐Strauss syndrome in a French urban multiethnic population in 2000: A capture–recapture estimate · Alfred Mahr · 2004 · 553 citations · Cited by this paper
  35. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease · J. Charles Jennette · 2014 · 501 citations · Cited by this paper
  36. ANCA-Associated Vasculitis: Core Curriculum 2020 · Duvuru Geetha · 2019 · 493 citations · Cited by this paper
  37. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis · Daigo Nakazawa · 2018 · 489 citations · Cited by this paper
  38. Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis · Xavier Bossuyt · 2017 · 470 citations · Cited by this paper
  39. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2 · Carmelo Carmona‐Rivera · 2014 · 464 citations · Cited by this paper

Source: OpenAlex (CC0)